A Danish study arriving at the European diabetes conference in Milan offers a sobering clarification of what gestational diabetes truly means across a woman's lifetime. What medicine has long treated as a temporary condition of pregnancy appears to leave a lasting metabolic signature — one that pulls the onset of type 2 diabetes nearly thirteen years earlier and delivers it in a more demanding form. The research invites a quiet reckoning with how medicine frames risk, and whether the end of pregnancy should also mark the beginning of a longer, more attentive conversation.
Gestational diabetes history accelerates type 2 diabetes onset by 13 years
Women with gestational diabetes history face substantially earlier onset of type 2 diabetes requiring more intensive insulin treatment, affecting quality of life and long-term health outcomes.